抄録
The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy. The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy.
| 本文言語 | English |
|---|---|
| ページ（範囲） | 153-156 |
| ページ数 | 4 |
| ジャーナル | Cell stem cell |
| 巻 | 22 |
| 号 | 2 |
| DOI |
|
| 出版ステータス | Published - 2018 2月 1 |
ASJC Scopus subject areas
- 分子医療
- 遺伝学
- 細胞生物学